Aaron N. Hata
0000-0002-6127-318X
Publication & Citation Trends
Publications
0 total
Prevalence and Actionability of MTAP Loss in Oncogene-Driven Lung Cancer
Cited by 1
Semantic Scholar
Targeted therapy-induced chromosomal instability dictates mitotic dependency on Aurora Kinase A
Cited by 0
Semantic Scholar
ApoFLARE: a luminescent reporter for direct quantification of APOBEC3A editing activity
Cited by 0
Semantic Scholar
Antibody peptide epitope conjugates for αPD-1 therapy-resistant head and neck squamous cell carcinoma
Cited by 0
Semantic Scholar
Targeting Monounsaturated Fatty Acid Metabolism for Radiosensitization of KRAS Mutant 3D Lung Cancer Models.
Cited by 2
Semantic Scholar
MUCIN 1 confers inflammatory memory of tyrosine kinase inhibitor resistance in non-small cell lung cancer
Cited by 3
Semantic Scholar
A cellular and spatial atlas of TP53-associated tissue remodeling defines a multicellular tumor ecosystem in lung adenocarcinoma
Cited by 5
Semantic Scholar
STX-721, a Covalent EGFR/HER2 Exon 20 Inhibitor, Utilizes Exon 20–Mutant Dynamic Protein States and Achieves Unique Mutant Selectivity Across Human Cancer Models
Cited by 2
Semantic Scholar
An ultrasensitive method for detection of cell-free RNA
Cited by 30
Semantic Scholar
Research Topics
Lung Cancer Treatments and Mutations
(241)
Lung Cancer Research Studies
(150)
Cancer Genomics and Diagnostics
(64)
Cancer therapeutics and mechanisms
(61)
RNA modifications and cancer
(55)
Affiliations
University of California, Riverside
Argonne National Laboratory
Tufts Medical Center
Harvard University
Vanderbilt University